Hemolytic uremic syndrome and rhabdomyolysis in a patient with succinate coenzyme Q reductase (complex II) deficiency

Clinical Nephrology

Volumn 76, Issue 1, 2011, Pages 68-73

  Micheletti, M V ^a   Lavoratti, G ^a   Gasperini, S ^a   Donati, M A ^a   Pela, I ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute renal failure; Hemolytic uremic syndrome; Oxidative phosphorylation; Rhabdomyolysis; Succinate coenzyme Q reductase (complex II) deficiency

Indexed keywords

ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CARNITINE; COMPLEMENT FACTOR H; CREATINE KINASE; RIBOFLAVIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE;

AGENESIS; ANTIBIOSIS; ANTIBIOTIC THERAPY; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CASE REPORT; CHILD; COMPLEX II DEFICIENCY; CYSTOGRAPHY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES CULTURE; FEEDING DISORDER; FLUID THERAPY; HEMATURIA; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FAILURE; MALE; MUSCLE BIOPSY; OXIDATIVE PHOSPHORYLATION; PRESCHOOL CHILD; PROTEINURIA; RECURRENT DISEASE; RHABDOMYOLYSIS; SEPSIS; SODIUM RETENTION; THROMBOCYTOPENIA; URINARY TRACT INFECTION; URINE CULTURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYMOLOGY; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

CHILD, PRESCHOOL; ELECTRON TRANSPORT COMPLEX II; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; RHABDOMYOLYSIS;

EID: 80051765761     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106681     Document Type: Article

References (27)

1. Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005; 16: 1035-1050.
2. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347: 589-600.
3. Geraghty MT, Perlman EJ, Martin LS, Hayflick SJ, Casella JF, Rosenblatt DS, Valle D. Cobalamin C defect associated with hemolytic-uremic syndrome. J Pediatr. 1992; 120: 934-937.
4. Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol. 2002; 24: 327-329.
5. Van Hove JL, Van Damme-Lombaerts R, Grunewald S, Peters H, Van Damme B, Fryns JP, Wevers R, Baumgartner ER, Fowler B. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am J Med Genet. 2002; 111: 195-201.
6. Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol. 2007; 22: 2097-2103.
7. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001; 60: 831-846.
8. Andreoli SP, Bergstein JM. Acute rhabdomyolysis associated with hemolytic-uremic syndrome. J Pediatr. 1983; 103: 78-80.
9. Pena DR, Vaccarello M, Neiberger RE. Severe hemolytic uremic syndrome associated with rhabdomyolysis and insulin-dependent diabetes mellitus. Child Nephrol Urol. 1991; 11: 223-227.
10. Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am. 1992; 39: 821-858.
11. Saunier P, Chretien D, Wood C, Rotig A, Bonnefont J, Saudubray J, Rabier D, Munnich A, Rustin P. Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria. Neuromusc Disord. 1995; 1: 285-289.
12. Tein I, Di Mauro S, De Vivo DC. Recurrent childhood myoglobinuria. Adv Pediatr. 1990; 37: 77-117.
13. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. 2006; 118: 2119-2125.
14. Tarr PI, Fouser LS, Stapleton AE, Wilson RA, Kim HH, Vary JC Jr, Clausen CR. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N Engl J Med. 1996; 335: 635-638.
15. Shoffner JM. Oxidative Phosphorylation Diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds). The Metabolic? Molecular Bases of Inherited Diseases. New York: McGraw-Hill Medical Publishing Division; 2001. p. 2367-2423.
16. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003; 348: 2656-2668.
17. Solhaug MJ, Ballevre LD, Guignard JP, Granger JP, Adelman RD. Nitric oxide in the developing kidney. Pediatr Nephrol. 1996; 10: 529-539.
18. Westenfeld R, Gawlik A, de Heer E, Kitahara M, Abou-Rebyeh F, Floege J, Ketteler M. Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritis. Kidney Int. 2002; 61: 834-838.
19. Ignarro LJ. Physiology and pathophysiology of nitric oxide. Kidney Int. 1996; 49: 2-5.
20. Koga Y, Akita Y, Junko N, Yatsuga S, Povalko N, Fukiyama R, Ishii M, Matsuishi T. Endothelial dys-function in MELAS improved by l-arginine supplementation. Neurology. 2006; 66: 1766-1769.
21. Maroescka te Loo D, Monnens L, van der Velden T, Karmali M, van den Heuvel L, van Hinsbergh V. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells. Pediatr Nephrol. 2006; 21: 1815-1823.
22. Siegler RL, Pysher TJ, Tesh VL, Noris M, Cassis P, Taylor FB. Reduced nitric oxide bioavailability in a baboon model of Shiga toxin mediated hemolytic uremic syndrome. Ren Failure. 2005; 27: 635-641.
23. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol. 1991; 5: 733-742.
24. Noris M, Ruggenenti P, Todeschini M et al. Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G. Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator for microvascular injury. Am J Kidney Dis. 1996; 27: 790-796.
25. Loirat C, Noris M, Frameaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2008; 23: 1957-1972.
26. Frameaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey MA, Strain L, Loirat C, Deng HW, Goodship THJ. The development of atypical hemo lytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet. 2005; 42: 852-856.
27. Caprioli J, Castelletti F, Bucchioni S et al. Bettinaglio P, Bresin E, Pianetti g, Gamba S, Brioschi s, Daina E, Remuzzi G, Noris M. International Registry of Recurrent and Familial HUS/TTP. Complement factor H mutations and gene polymorphisms in hemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet. 2003; 12: 3385-3395.